Transient and permanent engraftment potential of murine hematopoietic stem cell subsets: differential effects of host conditioning with gamma radiation and cytotoxic drugs
- PMID: 8100536
Transient and permanent engraftment potential of murine hematopoietic stem cell subsets: differential effects of host conditioning with gamma radiation and cytotoxic drugs
Abstract
Transplant of sorted donor (B6-Gpi-1a) hematopoietic stem cell subsets and host (B6-Gpi-1b) treatment with total body irradiation (TBI) or cytotoxic drugs were compared for induction of short- and long-term engraftment in a murine chimera model of congenic bone marrow transplantation (BMT). Parallel studies on donor and host marrow were performed in vitro in long-term bone marrow cultures to determine early and late cobblestone area forming cell (CAFC) frequencies in the grafts or in the transplant recipients 1 day after conditioning. Bone marrow cells (BMC) sorted for high wheat germ agglutinin affinity (WGA ) were enriched about 30-fold for early developing CAFC (colony-forming unit-spleen [CFU-S]) but not for primitive late CAFC (pre-CFU-S). This fraction showed only temporary engraftment when transplanted in irradiated recipients. In contrast, the low affinity (WGA+) fraction were preferentially enriched (200- to 300-fold) for late developing CAFC and were very effective for providing stable long-term engraftment following transplantation. Substituting radiation for chemotherapy in the host conditioning treatment also had diverse effects on the development of bone marrow engraftment. Pretreatment with 5-fluorouracil (5-FU, 200 mg/kg) allowed a discrete wave of donor engraftment that peaked at 2 to 4 weeks and then subsided to leave mostly host cells at 10 weeks and beyond. Busulfan preparation gave over 50% engraftment at 1 month after BMT but this continued to increase to reach stable donor chimerism of 80 to 90% beyond 10 weeks. The level of long-term engraftment given by 50 mg/kg busulfan appeared similar to that induced by doses of 6 to 8 Gy TBI. The changing patterns of erythroid chimerism for each preparative agent showed a remarkable correlation with depletion of defined hematopoietic stem cell subsets as quantified using the CAFC assay at 1 day after recipient treatment. These findings collectively show that the level of depletion of host CFU-S (CAFC-10) determines the extent of early and transient repopulation, whereas the degree of pre-CFU-S (CAFC-35) depletion determines the percentage of stable chimerism. Preliminary data on bone marrow CAFC content at 9 months after busulfan and BMT revealed a long-term reduction of the stem cell pool by about 50% but with relatively minor effects on supporting bone marrow stromas. The differential cytotoxic effects on stem cell subsets in relation to subsequent donor marrow engraftment offer a systematic and mechanistic approach toward identifying more effective chemotherapeutic compounds for use in clinical BMT conditioning regimens.
Similar articles
-
Stem cell factor has contrasting effects in combination with 5-fluorouracil or total-body irradiation on frequencies of different hemopoietic cell subsets and engraftment of transplanted bone marrow.Radiat Res. 1997 Jun;147(6):680-5. Radiat Res. 1997. PMID: 9189165
-
Comparison of different busulfan analogues for depletion of hematopoietic stem cells and promotion of donor-type chimerism in murine bone marrow transplant recipients.Cancer Res. 2000 Oct 1;60(19):5470-8. Cancer Res. 2000. PMID: 11034090
-
Thiotepa improves allogeneic bone marrow engraftment without enhancing stem cell depletion in irradiated mice.Bone Marrow Transplant. 1998 Feb;21(4):327-30. doi: 10.1038/sj.bmt.1701103. Bone Marrow Transplant. 1998. PMID: 9509964
-
Hematopoietic cell transplantation for the induction of allo- and xenotolerance.Clin Transplant. 1996 Aug;10(4):357-63. Clin Transplant. 1996. PMID: 8884109 Review.
-
Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.Blood Cells Mol Dis. 2008 Jan-Feb;40(1):48-54. doi: 10.1016/j.bcmd.2007.06.019. Epub 2007 Sep 10. Blood Cells Mol Dis. 2008. PMID: 17827036 Review.
Cited by
-
Complete correction of murine Artemis immunodeficiency by lentiviral vector-mediated gene transfer.Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16406-11. doi: 10.1073/pnas.0608130103. Epub 2006 Oct 24. Proc Natl Acad Sci U S A. 2006. PMID: 17062750 Free PMC article.
-
Tolerization of a type I allergic immune response through transplantation of genetically modified hematopoietic stem cells.J Immunol. 2008 Jun 15;180(12):8168-75. doi: 10.4049/jimmunol.180.12.8168. J Immunol. 2008. PMID: 18523282 Free PMC article.
-
Relationships between ablation of distinct haematopoietic cell subsets and the development of donor bone marrow engraftment following recipient pretreatment with different alkylating drugs.Br J Cancer. 1994 Oct;70(4):611-6. doi: 10.1038/bjc.1994.359. Br J Cancer. 1994. PMID: 7917905 Free PMC article.
-
A robust and rapid xenograft model to assess efficacy of chemotherapeutic agents for human acute myeloid leukemia.Blood Cancer J. 2015 Mar 20;5(3):e297. doi: 10.1038/bcj.2015.19. Blood Cancer J. 2015. PMID: 25794133 Free PMC article.
-
A Murine 5-Fluorouracil-Based Submyeloablation Model for the Study of Bone Marrow-Derived Cell Trafficking in Reproduction.Endocrinology. 2016 Oct;157(10):3749-3759. doi: 10.1210/en.2016-1418. Epub 2016 Jul 18. Endocrinology. 2016. PMID: 27427897 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources